Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Name: Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
License: Public Domain

BerGenBio ASA

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lung cancer metastatic, nsclc stage iv, adenocarcinoma of lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 321708
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.